Bumetanide Tablet
Product Images NDC 0615-8616

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 0615-8616). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structural Formula (Bumetanide 8614 8615 8616 1)

FDA Label Image

Principal Display Panel (Bumetanide 8614 8615 8616 2)

Principal Display Panel (Bumetanide 8614 8615 8616 2)
This text appears to be a detailed description of pharmaceutical tablets containing Bumetanide. The tablets are available in different strengths, such as 0.5 mg and 0.6 mg. The packaging includes various lot numbers, and there are specific storage instructions provided. The tablets are intended for institutional use only. The text also mentions the trademark of the packaging design belonging to Omnicare, Inc. Please consult with a healthcare professional for detailed prescribing and dosage information.*
FDA Label Image

Principal Display Panel (Bumetanide 8614 8615 8616 3)

Principal Display Panel (Bumetanide 8614 8615 8616 3)
This text contains detailed information about Bumetanide tablets, USP 1 mg, including manufacturing details, packaging information, lot numbers, storage instructions, and dosage guidelines. It also mentions that the tablets are for institutional use only. The tablets contain Bumetanide USP 1 mg each and should be stored at a controlled room temperature. It provides instructions to see the package insert for full prescribing information and mentions that the tablets are distributed by Vangard Labs in Glasgow, KY. It includes various lot numbers and trademarks associated with the packaging.*
FDA Label Image

Principal Display Panel (Bumetanide 8614 8615 8616 4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.